MAGE-A Antigens and Cancer Immunotherapy

Related Experiment Video

Updated: Mar 5, 2026

Enrich and Expand Rare Antigen-specific T Cells with Magnetic Nanoparticles
09:28

Enrich and Expand Rare Antigen-specific T Cells with Magnetic Nanoparticles

Published on: November 17, 2018

12.1K

Paul Zajac1, Elke Schultz-Thater1, Luigi Tornillo2

  • 1Oncology Surgery, Department of Biomedicine, University Hospital of Basel , Basel , Switzerland.

Frontiers in Medicine
|March 25, 2017
PubMed

Insights

Melanoma-associated antigen (MAGE-A) specific immunotherapies show promise for treating various cancers due to tumor specificity. This review analyzes current MAGE-A clinical trials and discusses future improvements for cancer treatment.

Area of Science:

  • Oncology
  • Immunology
  • Cancer Research

Background:

  • Melanoma-associated antigen (MAGE-A) proteins are expressed in various cancers and germ cells.
  • MAGE-A antigens exhibit high tumor specificity, making them ideal targets for cancer immunotherapy.
  • Current immunotherapies leverage MAGE-A antigens for targeted cancer treatment.

Purpose of the Study:

  • To review existing and ongoing clinical studies focused on MAGE-A antigen-targeted immunotherapies.
  • To critically analyze the benefits and drawbacks of different therapeutic strategies.
  • To explore potential advancements for enhancing MAGE-A-specific cancer immunotherapies.

Main Methods:

  • Comprehensive literature review of clinical studies.
  • Analysis of therapeutic approaches targeting MAGE-A antigens.
  • Discussion of future directions in MAGE-A immunotherapy.

Main Results:

  • MAGE-A antigens are validated targets in diverse cancers.
  • Various active specific and adoptive immunotherapy approaches are under investigation.
  • Clinical efficacy and safety profiles vary across different MAGE-A-targeting strategies.

Conclusions:

  • MAGE-A-specific immunotherapies offer a promising avenue for cancer treatment.
  • Further research is needed to optimize therapeutic strategies and overcome challenges.
  • Advancements in MAGE-A immunotherapy hold potential for improved patient outcomes in oncology.
Keywords:
MAGE-Aadoptive immunotherapycancer immunotherapycancer–testis antigensclinical trials

More Related Videos

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development11:02

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 30, 2013

21.8K
A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

1.5K

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
1.7K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.2K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.2K
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
6.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K